期刊文献+

肝硬化并上消化道出血患者预后的影响因素 被引量:24

Influencing Factors of Prognosis on Patients with Upper Gastrointestinal Hemorrhage Induced by Cirrhosis
暂未订购
导出
摘要 目的探讨肝硬化并上消化道出血(UGH)患者预后的影响因素。方法 回顾性分析2003年6月至2009年6月我科196例肝硬化并UGH患者的临床资料。根据患者预后分为生存组与死亡组,比较两组病例的出血病因、既往出血史、24h内再出血、肝功能Child-Pugh分级、并发症(腹水、肝性脑病、肝肾综合征)、血常规(PLT、Hb)、重要生化指标(TBIL、ALB、Cr)及凝血相关指标(PT、TT、aPTT)等因素。结果 死亡组出血原因中食管胃静脉曲张出血发生率高于生存组,门脉高压性胃病出血发生率低于生存组(P<0.01);两组在上述其他观察指标间差异均有统计学意义(P<0.05,P<0.01)。结论 出血病因、既往出血史、24h内再出血、肝功能分级、并发症、重要生化指标(PLT、Hb、TBIL、ALB、Cr)及凝血因子水平均影响肝硬化并上消化道出血患者的转归,可作为评价此病预后的重要指标。 Objective To explore the influencing factors of prognsis on patients with upper gastrointestinal hemorrhage(UGH) induced by cirrhosis.Methods The clinical date of 196 cases with UGH induced by cirrhosis from June 2003 to June 2009 were retrospectively analyzed.Cases were divided into survival group and dead group according to their prognosis,and the predisposing factors of the two groups which included the hemorrhage causes,UGH history,rebleeding within 24 hours,Child-Pugh grade,complications(ascites,hepatic encephalopathy,hepatorenal syndrome),blood routine(PLT,Hb),important biochemical parameters(TBIL,ALB,Cr) and coagulation-related indicators(PT,TT,aPTT) were compared.Results Of bleeding causes,the dead group was higher in esophageal variceal bleeding and less in portal hypertensive gastropathy bleeding than the survival group(P0.01).There were signficant differces in above other observing parameters between the two groups(P0.05,P0.01).Conclusion The hemorrhage causes,UGH history,rebleeding within 24 hours,liver function grade,complications,important parameters(PLT,Hb,TBIL,ALB,Cr) and coagulation factors level could influence survival rate of cirrhosis complicated with UGH and be used as important indicators to determine prognsis of the disease.
出处 《临床消化病杂志》 2011年第1期43-45,共3页 Chinese Journal of Clinical Gastroenterology
关键词 肝硬化 上消化道出血 预后 影响因素 Cirrhosis Upper gastrointestinal hemorrhage Prognosis influence factors
  • 相关文献

参考文献11

二级参考文献22

  • 1吴勇.奥曲肽治疗肝硬化并上消化道出血32例临床观察[J].中国医师杂志,2002,4(S1). 被引量:2
  • 2陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1997.1585.
  • 3王吉耀.内科学[M].北京:人民卫生出版社,2001.575-576.
  • 4Nomura S,Ogami K,Kawamura K,et al.Cellular localization of thrombopoietin mRNA in the liver by in situ hybridization[J].Exp Hematol,1997,25 (7):565-572.
  • 5Shimodaira S,Ishida F,Ichikawa N,et al.Serum thrombopoietin (c-mpl ligand)levels in patients with liver cirrhosis[J].Thromb Haemost,1996,76(4):545 -548.
  • 6Peck RM,Zacherl J,Wichlas M,et al.Thrombopoitic cytokins and reversal of thrombocytopenia after liver transplantation[J].Eur J Gastroenterol Hepatol,1999,11 (2):151-156.
  • 7Matin TG,Somberg KA,Meng YG,et al.Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplatation[J].An Intern Med,1997,127(8):285-289.
  • 8Burak KW ,Lee SS,Beck PL. Portal hypertensive gastropathy and gastric antral vascular ectasiaa (GAVE) syndrome[J]. Gut,2001,49:866-872
  • 9刘渲然,耿洪业,刘运清.上消化道出血研究[M].青岛:青岛出版社,1993,289-291
  • 10徐希岳 王启之 田怡.肝炎后肝硬化脾功能亢进时的骨髓象变化.临床肝胆病杂志,1990,6(4):207-208.

共引文献14077

同被引文献126

引证文献24

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部